1. Home
  2. BSX vs BLK Comparison

BSX vs BLK Comparison

Compare BSX & BLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BSX
  • BLK
  • Stock Information
  • Founded
  • BSX 1979
  • BLK 1988
  • Country
  • BSX United States
  • BLK United States
  • Employees
  • BSX N/A
  • BLK N/A
  • Industry
  • BSX Medical/Dental Instruments
  • BLK Investment Bankers/Brokers/Service
  • Sector
  • BSX Health Care
  • BLK Finance
  • Exchange
  • BSX Nasdaq
  • BLK Nasdaq
  • Market Cap
  • BSX 157.6B
  • BLK 170.2B
  • IPO Year
  • BSX 1992
  • BLK 1999
  • Fundamental
  • Price
  • BSX $98.22
  • BLK $1,137.06
  • Analyst Decision
  • BSX Strong Buy
  • BLK Strong Buy
  • Analyst Count
  • BSX 22
  • BLK 14
  • Target Price
  • BSX $118.91
  • BLK $1,150.57
  • AVG Volume (30 Days)
  • BSX 8.1M
  • BLK 447.8K
  • Earning Date
  • BSX 10-22-2025
  • BLK 10-10-2025
  • Dividend Yield
  • BSX N/A
  • BLK 1.83%
  • EPS Growth
  • BSX 36.90
  • BLK 2.62
  • EPS
  • BSX 1.68
  • BLK 41.34
  • Revenue
  • BSX $18,494,000,000.00
  • BLK $21,573,000,000.00
  • Revenue This Year
  • BSX $19.75
  • BLK $16.07
  • Revenue Next Year
  • BSX $11.03
  • BLK N/A
  • P/E Ratio
  • BSX $58.57
  • BLK $27.52
  • Revenue Growth
  • BSX 21.44
  • BLK 15.45
  • 52 Week Low
  • BSX $80.64
  • BLK $773.74
  • 52 Week High
  • BSX $109.50
  • BLK $1,171.89
  • Technical
  • Relative Strength Index (RSI)
  • BSX 27.91
  • BLK 57.28
  • Support Level
  • BSX $104.24
  • BLK $1,106.61
  • Resistance Level
  • BSX $109.50
  • BLK $1,141.83
  • Average True Range (ATR)
  • BSX 2.15
  • BLK 18.56
  • MACD
  • BSX -1.04
  • BLK 1.02
  • Stochastic Oscillator
  • BSX 8.59
  • BLK 76.52

About BSX Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

About BLK BlackRock Inc.

BlackRock is the largest asset manager in the world, with $12.528 trillion in assets under management at the end of June 2025. Its product mix is diverse, with 54% of managed assets in equity strategies, 25% in fixed income, 8% in multi-asset classes, 8% in money market funds, and 5% in alternatives. Passive strategies account for two-thirds of long-term AUM, with the company's ETF platform maintaining a leading market share domestically and on a global basis. Product distribution is weighted more toward institutional clients, which, by our calculations, account for around 80% of AUM. BlackRock is geographically diverse, with clients in more than 100 countries and more than one-third of managed assets coming from investors domiciled outside the US and Canada.

Share on Social Networks: